6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine.
作者信息
Park B K, Eichelbaum M, Ohnhaus E E
出版信息
Br J Clin Pharmacol. 1982 May;13(5):737-40. doi: 10.1111/j.1365-2125.1982.tb01448.x.
Abstract
摘要
相似文献
1
6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine.6-羟基皮质醇排泄与鹰爪豆碱多态性N-氧化的关系。
Br J Clin Pharmacol. 1982 May;13(5):737-40. doi: 10.1111/j.1365-2125.1982.tb01448.x.
2
The influence of enzyme induction on polymorphic sparteine oxidation.酶诱导对多态性司巴丁氧化的影响。
Br J Clin Pharmacol. 1986 Jul;22(1):49-53. doi: 10.1111/j.1365-2125.1986.tb02879.x.
3
Sparteine oxidation polymorphism in Greenlanders living in Denmark.生活在丹麦的格陵兰人的鹰爪豆碱氧化多态性
Br J Clin Pharmacol. 1986 Oct;22(4):415-9. doi: 10.1111/j.1365-2125.1986.tb02911.x.
4
Sparteine oxidation polymorphism in Denmark.丹麦的鹰爪豆碱氧化多态性
Acta Pharmacol Toxicol (Copenh). 1985 Nov;57(5):357-60. doi: 10.1111/j.1600-0773.1985.tb00058.x.
5
Pharmacokinetics of midazolam in relation to polymorphic sparteine oxidation.咪达唑仑与多态性司巴丁氧化相关的药代动力学。
Br J Clin Pharmacol. 1986 Nov;22(5):618-20. doi: 10.1111/j.1365-2125.1986.tb02946.x.
6
Sparteine oxidation polymorphism: a family study.鹰爪豆碱氧化多态性：一项家族研究。
Br J Clin Pharmacol. 1986 Jun;21(6):661-7. doi: 10.1111/j.1365-2125.1986.tb05231.x.
7
Thin-layer chromatographic screening test for polymorphic sparteine oxidation.多态性司巴丁氧化的薄层色谱筛选试验
Ther Drug Monit. 1989;11(2):214-6. doi: 10.1097/00007691-198903000-00016.
8
Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population.日本人群中三种测试探针（美托洛尔、异喹胍和司巴丁）代谢率之间与遗传决定的氧化多态性的相关性。
Br J Clin Pharmacol. 1990 Jan;29(1):111-5. doi: 10.1111/j.1365-2125.1990.tb03609.x.
9
Sparteine metabolism in a Nigerian population.尼日利亚人群中的鹰爪豆碱代谢
Drug Metabol Drug Interact. 1996;13(2):129-35. doi: 10.1515/dmdi.1996.13.2.129.
10
Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.
Br J Clin Pharmacol. 1989 May;27(5):620-5. doi: 10.1111/j.1365-2125.1989.tb03426.x.
引用本文的文献
1
Addressing phenoconversion: the Achilles' heel of personalized medicine.应对表型转换：个性化医疗的致命弱点。
Br J Clin Pharmacol. 2015 Feb;79(2):222-40. doi: 10.1111/bcp.12441.
2
Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.尿6β-羟基皮质醇：一种用于评估人类和动物中通过CYP3A介导的药物诱导或药物抑制作用的有效检测方法。
Eur J Clin Pharmacol. 2003 Dec;59(10):713-33. doi: 10.1007/s00228-003-0690-3. Epub 2003 Nov 6.
3
Urinary bile acid and bile alcohol excretion does not reflect the genetic polymorphism of debrisoquine hydroxylation.尿胆汁酸和胆汁醇排泄不能反映异喹胍羟基化的遗传多态性。
Br J Clin Pharmacol. 1984 Apr;17(4):470-3. doi: 10.1111/j.1365-2125.1984.tb02374.x.
4
2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.乙炔雌二醇的2-羟基化与司巴丁和安替比林氧化的关系。
Br J Clin Pharmacol. 1984 Oct;18(4):603-7. doi: 10.1111/j.1365-2125.1984.tb02511.x.
5
Assessment of the drug metabolism capacity of the liver.肝脏药物代谢能力的评估。
Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x.
6
The influence of enzyme induction on polymorphic sparteine oxidation.酶诱导对多态性司巴丁氧化的影响。
Br J Clin Pharmacol. 1986 Jul;22(1):49-53. doi: 10.1111/j.1365-2125.1986.tb02879.x.
7
The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.尿中6β-羟基皮质醇排泄增加作为人类肝细胞色素P450IIIA诱导的标志物。
Br J Clin Pharmacol. 1989 Oct;28(4):373-87. doi: 10.1111/j.1365-2125.1989.tb03516.x.
本文引用的文献
1
6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine.6β-羟基皮质醇及其他极性皮质类固醇：人尿中的测定及其意义
J Clin Endocrinol Metab. 1961 Oct;21:1290-303. doi: 10.1210/jcem-21-10-1290.
2
Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.人体内去甲替林和安替比林清除率与异喹胍羟化作用的关系。
Life Sci. 1980 Nov 3;27(18):1673-7. doi: 10.1016/0024-3205(80)90642-6.
3
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.司巴丁N-氧化缺陷与异喹胍4-羟化的药物遗传学共变。
Eur J Clin Pharmacol. 1980 Feb;17(2):153-5. doi: 10.1007/BF00562624.
4
Deficient metabolism of debrisoquine and sparteine.异喹胍和鹰爪豆碱代谢缺陷。
Clin Pharmacol Ther. 1980 Apr;27(4):547-9. doi: 10.1038/clpt.1980.77.
5
Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.去甲丙咪嗪羟基化的基因控制缺陷对安替比林代谢物形成的影响。
Pharmacology. 1981;22(6):349-58. doi: 10.1159/000137515.
6
Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity.评估尿6β-羟基皮质醇作为混合功能加氧酶活性的体内指标。
Br J Clin Pharmacol. 1981 Aug;12(2):97-102. doi: 10.1111/j.1365-2125.1981.tb01186.x.
7
The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).苯巴比妥对狨猴（绢毛猴）尿中6β-羟基皮质醇排泄及肝酶活性的影响
Biochem Pharmacol. 1980 Dec;29(24):3319-24. doi: 10.1016/0006-2952(80)90310-x.
8
The effect of 3-methylcholanthrene on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).3-甲基胆蒽对狨猴（绢毛猴）尿中6β-羟基皮质醇排泄及肝酶活性的影响
Biochem Pharmacol. 1981 Aug 1;30(15):2131-4. doi: 10.1016/0006-2952(81)90233-1.
9
Urinary 17-hydroxycorticosteroid determination with p-hydrazinobenzenesulfonic acid-phosphoric acid.用对肼基苯磺酸 - 磷酸法测定尿17 - 羟皮质类固醇
Am J Clin Pathol. 1973 Nov;60(5):684-90. doi: 10.1093/ajcp/60.5.684.
10
A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine.人尿中6β-羟基皮质醇的直接放射免疫测定法。
J Steroid Biochem. 1978 Oct;9(10):963-6. doi: 10.1016/0022-4731(78)90058-4.
Zotero 插件